Clarity Pharmaceuticals Ltd (ASX: CU6) shares are having a strong session on Tuesday. At the time of writing, the ASX 200 share is up 7% to $3.52 after the company released a clinical trial update.

The cast of Emmerdale have spoken out following tonight's huge episode in which Cain Dingle revealed the truth to his wife Moira about his cancer diagnosis. Viewers know that Cain was recently ...

Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Bayer is directing investor attention back to its pharmaceutical development pipeline with a strategic move that signals more than just business as usual. The f ...

Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...